📚 Wiki Antimicrobial & Immune Arenicin

Arenicin

● Preclinical
Arenicin-1
Also known as: ARE-1, Lugworm Peptide
Page last reviewed

Quick Summary

Arenicin is a beta-hairpin antimicrobial peptide isolated from the coelomocytes of the lugworm Arenicola marina. It features a cyclic disulfide-bridged structure that confers broad-spectrum antibacterial and antifungal activity.

Antimicrobial Peptide Preclinical
Arenicin is a beta-hairpin antimicrobial peptide isolated from the coelomocytes of the lugworm Arenicola marina. It features a cyclic disulfide-bridged structure that confers broad-spectrum antibacterial and antifungal activity. Arenicin disrupts bacterial membranes and has been explored as a template for antibiotic drug design.
Storage Stability
Lyophilized
1–2 years (-20°C)
Reconstituted
~30 days (2–8°C)
Room temp
Avoid

Mechanism of Action

Membrane Disruption

Arenicin adopts a beta-hairpin conformation stabilized by a disulfide bond between Cys3 and Cys20. The amphipathic structure allows it to insert into bacterial membranes, forming pores or causing membrane dissolution. This mechanism is selective for bacterial membranes due to their high anionic lipid content.

Intracellular Targets

Beyond membrane disruption, arenicin may translocate into cells and interfere with intracellular targets including nucleic acids and protein synthesis machinery. This multi-target activity reduces the likelihood of resistance development.


Research Summary

Antibacterial Activity

Preclinical

Arenicin-1 demonstrates potent activity against gram-positive and gram-negative bacteria, including S. aureus, E. coli, and P. aeruginosa with MIC values in the low micromolar range. Analogs with improved selectivity and reduced hemolysis have been developed for pharmaceutical applications.

Drug Design Template

Preclinical

The compact disulfide-stabilized beta-hairpin scaffold of arenicin has been used as a template for rational antibiotic design. Modified analogs with substitutions at key positions show improved therapeutic indices and stability against proteolytic degradation.


Calculate your Arenicin dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →

Research Protocols

GoalDoseFrequencyRoute
In vitro MIC testing1-16 uMSingleAqueous solution
Membrane disruption studies2-8 uMSingleLiposome models

Arenicin is research-only. No established human protocols exist.


Interactions

Synergy
Additive membrane-disrupting effects in preclinical models
Neutral
Conventional Antibiotics
Complementary mechanisms; combination studies ongoing

Safety Profile

Arenicin-1 shows hemolytic activity at higher concentrations, limiting direct therapeutic use. Structural optimization has reduced this liability in analogs. Toxicity profiles are under investigation in preclinical models. No human safety data available.


References

  • [1]Ovchinnikova TV et al. (2004). Arenicin, an antimicrobial peptide from lugworm Arenicola marina, forms a secondary amphipathic structure in membrane-mimicking environments. FEBS Letters, 577(1-2), 209-214.
  • [2]Shenkarev ZO et al. (2011). Spatial structure, self-association, and membrane interactions of the antimicrobial peptide arenicin. Biochemistry, 50(28), 6255-6265.
Ready to dose Arenicin?
Get the exact syringe draw
You have read the research. Now run the math. Pick your vial size and BAC water volume, get IU draw in seconds.
Open the Calculator →
Verified Scientific Data Last audited:
Data Sources & External References
Source: peer-reviewed literature  ·  Domain: ascendpeptide.org

Suggest a Change

Arenicin · wiki page